|
|
|
 |
| Mix with the world of pharma products, people & solutions |
| |
|
|
|
CPhI China Presents: seminar on Navigating thenew regulatory environment for pharmaceutical innovation
|
| If you are looking to do business in China, seeking sound investment opportunities, and meet face-to-face with leading CMOs, CROs and pharmaceutical biotech companies join CPhI China 2016’s specialty forum for international professionals ! |
| |
| We are delighted to inform you that the Seminar on Navigating the new regulatory environment for pharmaceutical innovation will be held on 22 June at Shanghai New International Exhibition Centre, concurrently with CPhI & P-MEC China. |
| |
|
Since 2015, the Chinese central government has released a series of reform policies to address the problems in drug administration, which will greatly improve the environment of the Chinese pharmaceutical industry and support the development of overseas pharmaceutical companies in China.
|
| |
| CPhI, ICSE and P-MEC China, is organising a specialty forum for international visitors to take advantage of this opportunity. It is our goal to serve as the bridge to enhance international cooperation between domestic and international pharmaceutical companies. |
| |
| |
Forum Agenda |
|
Date: 09:30-11:35am, June 22, 2016
Venue: Shanghai New International Expo Center,
Hall E2 Meeting Room M17
Free of charge, simultaneous interpretation provided |
| Time |
Topic |
| 09:30-09:35 |
Opening remarks
Xu Ming, Vice President of China Chamber of Commerce for Import and Export of Medicines and Health Products |
| 09:35-09:55 |
New opportunities for Foreign Pharma/Biotech Companies in China – Chinese Regulatory Reform
Liu Weiqiang, Former Deputy Director of ShFDA GMP Department |
| 09:55-10:15 |
Development of Chinese CRO industry and sharing of successful story of CRO in China
Hui Cai, Vice President of Corporate Alliances and Head of Corporate Communications of WuXi AppTec |
| 10:15-10:35 |
Doing Business in China to adapt to the changing market environment for multinational pharmaceutical companies
Wang Ying, Pfizer China |
| 10:35-10:55 |
Measures to cope with changes in regulatory policies of IND in and outside China
Li Zhihe, President of Frontage Laboratories Inc. |
| 10:55-11:10 |
Healthcare Cross board Investment and M&A by Chinese Investors
Dr. Bing Li, Managing Director of Fosun Group, oversea PE investment for healthcare sector |
| 11:10-11:25 |
Investment Challenges and Opportunities in Healthcare Industry
Dr. Wenbao Li, Investment Director/Manager for healthcare/biotechnology investment of Morningside Technologies, Inc. and General Manager of Kunming Biomed International |
| 11:30-12:30 |
Networking and Lunch |
|
| |
| Click here for more seminar information>> |
| |
| Note: Seats are allocated on a first – come – first – served basis. |
|
|
|
|
| |
|
|
| |
|
 |
Download the registration form or contact Ms. Tina Zheng (tina.zheng@ubmsinoexpo.com) to secure your admission!! |
|
|
| |
| Co-lcoated Show Information |
| |
| CPhI China 2016 will be staged at Shanghai New International Expo Centre on June 21-23, 2016 together with ICSE & P-MEC China 2016, presenting a pharmaceutical gala event to the industry professionals. |
|
For over 15 years, CPhI & P-MEC China continues to extend the upstream and downstream of industry chain and now it has developed to an international top event with over 2,800 exhibitors covering the entire pharmaceutical industry chain. The event is trully a one stop trade platform gathering API, fine chemical & intermediates, excipients & formulation, CRO & CMO, biopharmaceuticals, natural extracts, dosage, pharma machinery, packaging equipment & material, laboratory equipment, environmental protection & clean technology as well as pharma logistics.
|
| |
|
|
| |
| |
|
|
